New corporate leadership is driving innovation from the lab to the clinic.
About Cytimmune
Cytimmune is a biotechnology company that has invented, patented, and developed a set of novel technologies designed to treat solid tumor cancers. Our IO+ platform has the potential to turn hot tumors cold, remodel the tumor environment, and kill cancer cells through multiple mechanisms.
Cytimmune’s lead therapeutic, CYT-6091, is preparing to enter phase 2 clinical studies at the National Cancer Institute (NCI). Our phase 1 trial at the NCI demonstrated the ability of the IO+ platform to deliver up to 4x the previous maximum tolerated dose of TNF alpha with no dose-limiting side effects observed.
Our Collaborators Span the Globe
We have received multiple grants from the National Institute of Standards and Technology, technical support from the U.S. Food and Drug Administration, and the Nanotechnology Characterization Lab at the NIH, and have an active clinical trial agreement with the U.S. National Cancer Institute.
We are proud to work with academic partners at top-tier research institutions in the U.S., Europe, Japan, and Australia.
Our Scientific Advisors are leaders in the fields of oncology, immunology, and chemistry
Dr. Kouji Matsushima was awarded honors in 2019 by the International Cytokine Society (ICS) after a previous role as President of the 2017 annual ICS conference in Kanazawa, Japan.
Board of Directors
Marc Stanley
Marc is currently retired, but continues to act as a special advisor to the Director of NIST. During his tenure, Marc served in multiple roles at NIST, including Director of the Technology Innovation Program, and Director of the Advanced Technology Program. Prior to NIST, Marc held senior roles at the Commerce Department, including associate deputy secretary and assistant secretary for congressional and intergovernmental affairs.
Ira Shapiro
Ambassador Ira Shapiro is a senior advisor to the Albright Stonebridge Group, the global consulting firm co-chaired by former Secretary of State Madeleine Albright and former Secretary of Commerce Carlos Gutierrez. Ira previously held senior staff positions in the U.S. Senate and served as General Counsel, Ambassador, and chief trade negotiator with Japan and Canada in the Office of the U.S. Trade Representative during the Clinton administration.
Ken Itani
Ken founded multiple private and publicly traded technology companies with operations in the U.S., Europe, and Japan. He previously served as a Director with the Carnegie Group, and early in his career worked as a Project Manager with Rockwell Aerospace & Astronautics. Ken received a BA in Economics from the International Christian University in Tokyo, an MPA in Econometrics/Financial Policy from the University of Pittsburgh, and an MS in Information Science from Carnegie Mellon University.